PDL BioPharma Inc (NASDAQ:PDLI) Investor Alert: Lawsuit Alleges Securities Laws Violations

San Diego, CA -- (SBWIRE) -- 09/22/2014 -- An investor, who purchased shares of PDL BioPharma Inc (NASDAQ:PDLI), filed a lawsuit in the U.S. District Court for the District of Nevada over alleged violations of Federal Securities Laws by PDL BioPharma Inc in connection with certain allegedly false and misleading statements made between November 6, 2013 and September 16, 2014.